Area of research
Orthopedics and Sports Medicine · Oncology
Research interest
Research interests include Medicine, Osteoporosis, Placebo, Bone mineral, Population, and Incidence (geometry).
Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study
Osteoporotic fracture trends in a population of US managed care enrollees from 2007 to 2017
ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
Characteristics of recurrent fractures
Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis
Effects of Abaloparatide-SC on Fractures and Bone Mineral Density in Subgroups of Postmenopausal Women With Osteoporosis and Varying Baseline Risk Factors